Pioneering solutions to save and improve lives
Research is critical to combatting brain disease and improving the lives of those impacted, today and in the future.
Conducted by The Royal Melbourne Hospital’s Departments of Neurology and Neurosurgery, the active research programs and clinical trials supported by the Foundation cover an extensive breadth of neurological conditions.
Patients wishing to participate are encouraged to view the relevant trial and contact the trial co-ordinator for more information.
Sponsors wishing to support clinical trials should contact the Foundation on +61 3 9342 8447 or email neuro.foundation@mh.org.au.
A Phase IIIb Multicenter, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis
Assessment of whether Cladribine reconfigures mononuclear cells to a reparative M2-like phenotype
Retrospective analyses of clinically acquired MRI in multiple sclerosis
Prospective clinic and home-based serial monitoring of cognition in relapsing- remitting multiple sclerosis
A prospective, multicenter, observational, post-authorization safety study (PASS) to evaluate the long term safety profile of LEMTRADA® (alemtuzumab) treatment in patients with relapsing forms of multiple sclerosis